MDWD Mediwound Ltd.

MediWound Ltd is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel products to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and others.

$1.85  +0.11 (6.32%)
As of 08/05/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  Israel
IPO date:  03/20/2014
Outstanding shares:  33,140,633
Average volume:  152,030
Market cap:   $57,664,701
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   -4.08
PB ratio:   24.56
PS ratio:   2.43
Return on equity:   295.74%
Net income %:   -57.03%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy